Effects of gender and race on albuterol pharmacokinetics

Pharmacotherapy

Volumn 19, Issue 2, 1999, Pages 157-161

  Mohamed, Mohamad H N ^a   Lima, John J ^a   Eberle, Louis V ^b   Self, Timothy H ^a   Johnson, Julie A ^a,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; DRUG DISTRIBUTION; DRUG ELIMINATION; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; RACE DIFFERENCE; SEX DIFFERENCE;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALBUTEROL; BODY FLUID COMPARTMENTS; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; TISSUE DISTRIBUTION;

EID: 0032949328     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.3.157.30925     Document Type: Article

References (14)

1. Johnson JA. Influence of race or ethnicity on pharmacokinetics of drugs. J Pharm Sci 1997;86:1328-33.
2. Killer ME. Clinical trials and transethnic pharmacology. Drug Saf 1994;11:378-91.
3. Wood AJJ, Zhou HH. Ethnic differences in drug disposition and responsiveness. Clin Pharmacokinet 1991;20:350-73.
4. Harris RZ, Benet LZ, Schwanz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995;50:222-39.
5. Gleiter CH, Gundert-Remy U. Gender differences in pharmacokinetics. Eur J Drug Metab Pharmacokinet 1996;21:123-8.
6. Fletcher CV, Acosta EP, Strykowski JM. Gender differences in human pharmacokinetics and pharmacodynamics. J Adolesc Health 1994;15:619-29.
7. Berg MJ. Status of research on gender differences. J Am Pharm Assoc 1997;NS37:43-56.
8. Pacifi GM, Giulianetti B, Quilici MC, et al. (-)-Salbutamol sulphation in the human liver and duodenal mucosa: interindividual variability. Xenobiotica 1997;27:279-86.
9. Boulton DW, Fawcett JP. Enantioselective disposition of salbutamol in man following oral and intravenous administration. Br J Clin Pharmacol 1996;41:35-40.
10. Morgan DJ. Clinical pharmacokinetics of β-agonists. Clin Pharmacokinet 1990;18:270-94.
11. Expert Panel National Asthma Education Program. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1991.
12. Gupta RN, Fuller HD, Dolovich MB. Optimization of a column liquid chromatographic procedure for the determination of plasma salbutamol concentration. J Chromatogr B 1994;654:205-11.
13. Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. New York: Marcel Dekker, 1982.
14. Morgan DJ, Bray KM. Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet 1994;26:292-307.